ASCO: Cilta-Cel Beneficial for Lenalidomide-Refractory Multiple Myeloma
Single cilta-cel infusion results in lower risk of disease progression or death compared with standard care
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.